Zanubrutinib
Acalabrutinib
Obinutuzumab
Update Venetoclax in CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov
UpToDate
Leukemia & Lymphoma Society